CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.
| Revenue (TTM) | $6.76B |
| Gross Profit (TTM) | $6.76B |
| EBITDA | $4.77B |
| Operating Margin | 65.00% |
| Return on Equity | 15.80% |
| Return on Assets | 1.48% |
| Revenue/Share (TTM) | $18.78 |
| Book Value | $73.82 |
| Price-to-Book | 3.46 |
| Price-to-Sales (TTM) | 13.84 |
| EV/Revenue | 13.73 |
| EV/EBITDA | 15.24 |
| Quarterly Earnings Growth (YoY) | 2.50% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $359.58M |
| Float | $354.52M |
| % Insiders | 0.42% |
| % Institutions | 93.10% |
Volatility is currently contracting
Zacks Securities and Exchanges industry players like CME, ICE, NDAQ and CBOE gain from rising crypto adoption, a higher non-trading revenue base and tech investments. However, competition remains a drag.
CME Group has underperformed the S&P 500, declining nearly 12% over the past 11 months. CME delivered solid Q2 2026 results, with EPS of $2.99 and revenue of $1.71B, both of which beat analysts' expectations. Market Data revenue surged more than 20% compared to the same period a year ago.
CME Group is rated Buy, supported by record results and a resilient, defensible futures franchise. CME's moat is anchored in open interest and margin efficiencies, not just market share, insulating it from FMX's cash bond competition. Three underappreciated growth drivers: Treasury clearing, retail expansion, and crypto, are poised to fuel future compounding.
CME Group maintains strong core performance, posting record Q2 revenue and robust margins, yet the stock remains range-bound and fully valued. Q2 2026 highlights include $2.99 non-GAAP EPS, $1.71B revenue, 69.5% adjusted operating margin, and resilient trading volumes across key product lines. Capital return remains aggressive with $1.2B distributed via dividends and buybacks, backed by a strong balance sheet and disciplined expense management.
CME Group Inc. (CME) Q2 2026 Earnings Call Transcript
CME Group beats Q2 estimates as record market data revenues and resilient trading activity lift results, while expanding its product lineup.
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group NASDAQ: CME reported record second-quarter revenue and near-record trading activity, while executives used much of the company's second-quarter 2026 earnings call to address investor questions about perpetual futures and outline a slate of new product launches.
CME Group (CME) came out with quarterly earnings of $2.99 per share, beating the Zacks Consensus Estimate of $2.91 per share. This compares to earnings of $2.96 per share a year ago.
CHICAGO, July 22, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2026. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CME and any ticker you trade — then tracks every position and per-strategy win rate.
